Qeen Biotechnologies
Qeen Biotechnologies - Qeen BiotechnologiesQeen Biotechnologies

  • Home page
  • Solutions
    • Agriculture
      • Erwinia spp.
      • Ralstonia spp.
      • Xylella spp.
      • Xanthomonas spp.
    • Livestock Processing
      • Escherichia coli
      • Salmonella spp.
    • Aquaculture
      • Vibrio spp.
      • Mycobacterium spp.
      • Aeromonas spp.
      • Pseudomonas spp.
    • Human
      • Staphylococcus spp.
      • Pseudomonas spp.
      • Klebsiella spp.
      • Escherichia coli
      • Acinetobacter spp.
    • Veterinary
      • Staphylococcus spp.
      • Staphylococcus aureus
      • Pseudomonas aeruginosa
      • Campylobacter jejuni
      • Escherichia coli
    • Cosmeceuticals
    • Nutraceuticals
  • Services
    • Phage Characterization
    • Cell Banking
    • Fermentation and Upstream Processing
    • Downstream Processing
    • Advanced Quality Control
    • Laboratory Services
    • Regulatory Consulting Services
  • Product
    • Personalized Phage
  • About Us
    • Mission
    • Our Team
    • News
  • Patient
  • EN
    • FR
Contact us

Team

Qeen Biotechnologies > Team
Mr. Mark Engel
Chairman

Mr. Mark Engel

Dr. Nancy Tawil
CEO

Dr. Nancy Tawil

Qeen Biotechnologies is a global Center of Excellence in biomanufacturing non-traditional therapeutics. We provide services to develop and produce GMP and non-GMP bacteriophages and related delivery systems for the life sciences, pharmaceutical, agricultural, and veterinary industries.

SOLUTIONS

  • Agriculture
  • Human
  • Veterinary
  • Aquaculture
  • Livestock
  • Nutraceuticals
  • Cosmeceuticals

SERVICES

  • Biomanufacturing
  • Laboratory Services
  • Regulatory Consulting Services

About

  • Founders
  • About Us
  • News
Copyright © 2025 Qeen Biotechnologies. All rights reserved.